Further studies demonstrated that cetuximab selectively produces dose-dependent single agent cytotoxicity in certain NPC cell lines only, which might correlate with the level of EGFR protein expression [12]. The gene discussed is EGFR; the disease is nasopharyngeal carcinoma.